The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krivolapova A.Iu.

Meditsinskiĭ fakul'tet Sankt-Peterburgskogo gosudarstvennogo universiteta

Belousova I.E.

Military Medical Academy named after S.M. Kirov, RF Defence Ministry, St. Petersburg, Russia, 194044

Smirnova I.O.

Sankt-Peterburgskiĭ gosudarstvennyĭ universitet, Sankt-Peterburg, Rossiia, 199106

Lisukova E.V.

Nauchno-issledovatel'skiĭ institut detskoĭ onkologii, gematologii i transplantologii im. R.M. Gorbachevoĭ

Baĭkov V.V.

OOO "Roskardioinvest", Moskva

Diagnosis of cutaneous graft-versus-host disease: Pathomorphological aspects

Authors:

Krivolapova A.Iu., Belousova I.E., Smirnova I.O., Lisukova E.V., Baĭkov V.V.

More about the authors

Read: 1178 times


To cite this article:

Krivolapova AIu, Belousova IE, Smirnova IO, Lisukova EV, Baĭkov VV. Diagnosis of cutaneous graft-versus-host disease: Pathomorphological aspects. Russian Journal of Archive of Pathology. 2014;76(4):24‑28. (In Russ.)

Recommended articles:
Cardiac myxoma: biological features, morphology, differential diagnosis. Russian Journal of Archive of Pathology. 2024;(6):74-81
Quality control of immu­nohistochemical studies: compulsory duty or urgent need?. Russian Journal of Archive of Pathology. 2025;(2):43-52
Soli­tary fibrous tumor of the kidney. Russian Journal of Archive of Pathology. 2025;(3):77-81
Differential Diagnosis of Perianal Skin Neoplasms. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):673-678
Clinical Case of HIV-Associated Kaposi’s Sarcoma. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):782-786
Prevention and treatment of dermal toxi­city in children receiving anti-tumor radiation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):470-480

References:

  1. Hymes S.R., Alousi A.M., Cowen E.W. Graft-Versus-Host Disease. J. Am. Acad. Dermatol. 2012; 66 (4).
  2. Marra D.E., Mckee P.H., Nqhiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J. Am. Acad. Dermatol. 2007; 51 (4): 543-6.
  3. Jacobsohn D.A., Vogelsang G. Acute graft versus host disease. Orphanet J. Rare Dis. 2007; 4 (2): 35.
  4. Byun H.J., Yang J.I., Kim B.K. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J. Am. Acad. Dermatol. 2011; 65 (4): 726.
  5. Heldal D., Brinch L., Evensen S.A., Tjonnfjord G., Aamodt G., Elgjo K., Sviland L. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow. Bone Marrow Transplant. 2004; 34 (4): 345-50.
  6. Massi D., Franchi A., Pimpinelli N., Laszlo D., Bosi A., Santucci M. Value of the histopathological criteria for diagnosis of acute cutaneous graft-versus-host disease (aGVHD). Am. J. Dermatopathol. 1998; 20 (6): 613.
  7. Hippen K.L., Riley J.L., June C.H., Blazar B.R. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 2011; 23 (6): 462-8.
  8. Koreth J., Matsuoka K., Kim H., McDonough S.M., Bindra B., Alyea E.P. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 2011; 365 (22): 2055.
  9. Pan B., Zeng L., Cheng H., Song G. Altered balance between Th1 and Th17 cells in circulation is an indicator for the severity of murine acute GVHD. Immunol. Lett. 2012; 142 (1-2): 48-54.
  10. Li H., Kaplan D., Matte-Martone C., Tan H.S., Venkatesan S., Johnson K. Langerhans cells are not required for graft-versus-host disease. Blood. 2011; 117 (2): 697-707.
  11. Fondi C., Nozolli C., Benemei S., Baroni G., Saccardi R., Guidi S. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol. Blood Marrow Transplant. 2009; 15 (8): 938-47.
  12. Yan B., Da W. CD4+CD25+ regulatory T cells and their function in graft-versus-host disease-review. J. Exp. Hematol. 2006; 14 (2): 408-12.
  13. Korngold R., Sprent J. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J. Immunol. 1985; 135 (5): 3004-10.
  14. Kohler S., Hendrickson M.R., Chao N.J., Smoller B.R. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am. J. Surg. Pathol. 1997; 21 (9): 988-96.
  15. Shiohara J., Takata M., Shiohara M., Ito T., Ishida F. Hyperacute graft-versus-host disease: histological assessment of specimens skin biopsy from 19 cases. Clin. Exp. Dermatol. 2012; 37 (4): 335-40.
  16. Länger F., Puls F., Buchholz S., Loddenkemper C., Ganser A., Kreipe H. Histopathology of graft-versus-host disease. Pathologe. 2011; 32 (2): 144-51.
  17. Langley R.G., Walsh N., Nevill T., Thomas L., Rowden G. Apoptosis is the mode of keratinocyte death in cutaneous graft-versus-host disease. J. Am. Acad. Dermatol. 1996; 35: 187-90.
  18. Lerner K.G., Kao G.F., Storb R., Buckner C., Clift R., Thomas E. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant. Proc. 1974; 6 (4): 367-71.
  19. Murphy G.F., Korngold R. Significance of selectively targeted apoptotic rete cells in graft-versus-host disease. Biol. Blood Marrow Transplant. 2004; 10 (6): 357-65.
  20. Wang L., Romero M., Ratajczak P., Lebœuf C., Belhadj S., Peffault de Latour R. et al. Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia. Bone Marrow Transplant. 2013; 48 (6): 849-53.
  21. Weedon D. Weedon's skin pathology. 3rd ed. London: Churchill Livingstone Elsevier; 2010: 36-7.
  22. Ziemer M., Haeusermann P., Janin A., Massi D., Ziepert M., Wolff D. et al. Histopathological diagnosis of graft-versus-host disease of the skin - an interobserver comparison. J. Eur. Acad. Dermatol. Venereol. 2013; Aug 1. doi: 10.1111/jdv.12215.
  23. Giorgini A., Noble A. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. J. Leukocyte Biol. 2007; 82 (5): 1053-61.
  24. Pidala J., Anasetti C. Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse? Haematologica. 2010; 95 (4): 660-5.
  25. Li Q., Zhai Z., Xu X., Shen Y., Zhang A., Sun Z. et al. Our data showed a significant reduction in the frequency of Tregs in patients with grades II-IV aGVHD and extensive cGVHD compared to healthy controls. Leukemia Res. 2010; 34 (9): 1158-68.
  26. Chakraverty R., Sykes M. The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood. 2007; 110: 9-17.
  27. Andani R., Robertson I., Macdonald K.P., Durrant S., Hill G.R., Khosrotehrani K. Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation. Exp. Dermatol. 2014; 23 (1): 75-7.
  28. Kanda J., Nakasone H., Atsuta Y., Toubai T., Yokoyama H., Fukuda T. et al. Risk factors and organ involvement of chronic GVHD in Japan. Bone Marrow Transplant. 2014; 49 (2): 228-35.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.